Shares of Swiss bio-pharmaceutical company Actelion Ltd. (ALIOF.PK) gained around 17 percent on Friday after drug major Johnson & Johnson (JNJ) confirmed its preliminary talks with Actelion regarding a potential transaction. In its …
So just think what they could do to your child. I mention this as a public service announcement. It has nothing to do with my Johnson & Johnson stock falling one point because you stingy baby abusers are buying generics. Johnson &
Healthcare conglomerate Johnson & Johnson might be a $280-plus billion dollar company, but it's certainly not growing like one as evidenced by the company's robust growth reported in the second quarter. For the quarter, Johnson &
AbbVie is one drug stock that risk-tolerant investors should keep an eye on in 2016, due to its strong dividend payout and full-year 2016 EPS guidance. Johnson & Johnson (NYSE: JNJ) is another major drug manufacturer and S&P 500 …
Ben Bernanke, clearly no Keynesian, recently delivered a speech entitled "Economic Prospects for the Long Run." What, then, would he make of the extremely short-term stock gyrations caused by his every muttering? The Dow (^DJI), up …
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site …
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Schlumberger (SLB) and PayPal (PYPL). …
CHICAGO, Oct. 9, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DIS, JNJ, LLY, MZOR, …